Sidney Zisook, M.D. is a University of California San Diego (UCSD) Distinguished Professor of Psychiatry. He completed medical school at the Stitch-Loyola School of Medicine, residency at Massachusetts General Hospital and a clinical fellowship in psychiatry at Harvard University. As co-founder of the San Diego Chapter of American Foundation for Suicide Prevention (AFSP) in 2007, he launched and co-led a healthcare team suicide prevention program, the Healer Education, Assessment and Referral (HEAR ) program, for the UC San Diego medical school and health science community.

Melissa Zuckerman, MS, is the Chief Experience Officer (CXO) at the Dr. Lorna Breen Heroes' Foundation. As CXO, she brings engagements to life with clear vision and partnership – driving a unified approach to improve health workers' wellbeing and mental health. Prior to joining the Foundation, Melissa co-led JPA Health's public health practice in supporting nonprofit organizations, foundations, and professional associations in effectively engaging people and communities in public health education, healthcare professional support, and community involvement.

Dr. Vargas is a Mayo Clinic Consultant in the Department of Gastroenterology and Hepatology and the Mayo Clinic Transplantation Center. He is a Professor of Medicine in the Mayo Clinic Alix School of Medicine, where he is the Director for Research and a Associate Director for Medical School Affairs for the MD/PhD program in the Mayo Clinic Graduate School of Biomedical Sciences.<br>Dr. Vargas has authored or coauthored more than 190 peer-reviewed articles. He is a Fellow of the AASLD, AGA, ACG, ASGE and ACP.

Batuhan Yenilmez is an Assistant Professor at the University of Massachusetts Chan Medical School, where he leads a research program focused on developing next-generation RNA interference (RNAi)-based therapeutics in collaboration with world-renowned RNA chemists under the UMass Chan umbrella. His lab investigates metabolic and fibrotic diseases, with a particular emphasis on obesity, type 2 diabetes, metabolic dysfunction-associated steatohepatitis (MASH), and pulmonary fibrosis. By engineering tissue-selective RNAi molecules and exploring anti-fibrotic microRNAs, Dr.

Dr. Marshall Padilla received his PhD in Chemistry at the University of Wisconsin-Madison and is now an NIH Postdoctoral Fellow at the University of Pennsylvania's Department of Bioengineering in the Mitchell Lab. Dr. Padilla focuses on utilizing synthesis and biophysics to deeply characterize and rationally design lipid nanoparticles. He applies this knowledge to develop next-generation lipid nanoparticles for liver gene editing and cancer therapy, the latter through an NIH T90 fellowship.

Dr. Raeman is an Associate Professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and a core member of Pittsburgh Liver Research Center. Dr. Raeman earned his MS from Clemson University, PhD from the University of Georgia and completed his postdoctoral training at Emory University School of Medicine. Dr. Raeman specializes in delineating the cellular and molecular mechanisms of chronic liver diseases, specifically focusing on the role of gut-liver-immune axis in chronic liver disease progression. The current research in Dr.

Dr Akash Shukla from Mumbai, India has core area of interest is portal hypertension, complications of cirrhosis and vascular liver disorders. He's the first author on the APASL guidelines for management of Budd Chiari syndrome and recently published APASL Guidelines updates on NCPF / IPH. He was also on the steering committee of VALDIG, EASL and part of Baveno 7 panel.

Dr. Gerald Scott Winder is a Senior Staff Physician in the Departments of Psychiatry and Surgery at Henry Ford Health in Detroit, MI and a Clinical Professor of Psychiatry at Michigan State University. He holds a medical degree from the University of Utah School of Medicine and a Masters of Science degree from the University of Michigan School of Public Health. He is a fellow in the Academy of Consultation-Liaison Psychiatry. He completed a general psychiatry residency and a consultation-liaison psychiatry fellowship at the University of Michigan.

Professor of Hepatology at Department of Gastroenterology and Hepatology, Odense University Hospital and University of Southern Denmark. ORCID id: https://orcid.org/0000-0003-1854-1924<br><br>I work to reduce morbidity and mortality from alcohol-related liver disease and steatotic liver disease. My research centers on biomarker development and validation, with a particular focus on early disease detection, cost-effective referral pathways, and omics technologies.

Dr. El-Serag obtained his medical degree from Al-Arab Medical University in Libya, completed his internship and residency in internal medicine (1995) at Greenwich Hospital, Yale University, Connecticut, and completed a fellowship in gastroenterology (1997) at the University of New Mexico, Albuquerque, New Mexico, where he also earned a master's degree in public health (1998). In 1999, Dr. El-Serag joined the Michael E. DeBakey VA Medical Center and Baylor College of Medicine (BCM) in Houston, where he later became Chief of the Section of Gastroenterology & Hepatology (2007-2016).